<?xml version="1.0" encoding="UTF-8"?>
<ref id="med21743-bib-0583">
 <label>583</label>
 <mixed-citation publication-type="journal" id="med21743-cit-0583">
  <string-name>
   <surname>Bisson</surname>
   <given-names>J</given-names>
  </string-name>, 
  <string-name>
   <surname>McAlpine</surname>
   <given-names>JB</given-names>
  </string-name>, 
  <string-name>
   <surname>Friesen</surname>
   <given-names>JB</given-names>
  </string-name>, 
  <string-name>
   <surname>Chen</surname>
   <given-names>SN</given-names>
  </string-name>, 
  <string-name>
   <surname>Graham</surname>
   <given-names>J</given-names>
  </string-name>, 
  <string-name>
   <surname>Pauli</surname>
   <given-names>GF</given-names>
  </string-name>. 
  <article-title>Can invalid bioactives undermine natural product‐based drug discovery?</article-title>
  <source xml:lang="en">J Med Chem</source>. 
  <year>2016</year>;
  <volume>59</volume>:
  <fpage>1671</fpage>‐
  <lpage>1690</lpage>.
  <pub-id pub-id-type="pmid">26505758</pub-id>
 </mixed-citation>
</ref>
